Abstract Details

Title Primary Outcome Analysis of the Multicentre Phase II Trial of 18F-Flutemetamol, a Pittsburgh Compound B Derivative for In Vivo Beta Amyloid Imaging

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 007

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Rik R. Vandenberghe	No disclosure on file
	No disclosure on file
Adrian Ivanoiu, MD	No disclosure on file
	No disclosure on file
Eric Salmon, MD (Pfizer Belgium)	No disclosure on file
	No disclosure on file
Gunhild Waldemar, MD, DMSc (Rigshospitalet, Dept. of Neurology)	No disclosure on file
Steen Gregers G. Hasselbalch, MD (Rigshospitalet)	No disclosure on file
	No disclosure on file
Allan Andersen, MD, MSci (Gloslrup University Hospital)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file